BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 22381168)

  • 1. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.
    Lughezzani G; Burger M; Margulis V; Matin SF; Novara G; Roupret M; Shariat SF; Wood CG; Zigeuner R
    Eur Urol; 2012 Jul; 62(1):100-14. PubMed ID: 22381168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. European Association of Urology Guideline Group for urothelial cell carcinoma of the upper urinary tract].
    Rouprêt M; Zigeuner R; Palou J; Boehle A; Kaasinen E; Sylvester R; Babjuk M; Oosterlinck W;
    Actas Urol Esp; 2012 Jan; 36(1):2-14. PubMed ID: 22036956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of upper urinary tract urothelial carcinoma.
    Sun M; Abdo A; Abdollah F; Schmitges J; Thuret R; Jeldres C; Shariat SF; Perrotte P; Karakiewicz PI
    Expert Rev Anticancer Ther; 2010 Dec; 10(12):1955-65. PubMed ID: 21110761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic factors of upper tract urothelial carcinoma].
    Elalouf V; Klap J; Delongchamps NB; Conquy S; Sibony M; Saighi D; Peyromaure M; Flam T; Zerbib M; Xylinas E
    Prog Urol; 2013 Dec; 23(16):1382-8. PubMed ID: 24274942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
    Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Gontero P; Van Rhijn BWG; Mostafid AH; Palou J; Shariat SF
    Eur Urol; 2018 Jan; 73(1):111-122. PubMed ID: 28867446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European guidelines on upper tract urothelial carcinomas: 2013 update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester R; Burger M; Cowan N; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF;
    Eur Urol; 2013 Jun; 63(6):1059-71. PubMed ID: 23540953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma.
    Miyazaki Y; Kosaka T; Mikami S; Kikuchi E; Tanaka N; Maeda T; Ishida M; Miyajima A; Nakagawa K; Okada Y; Sato Y; Oya M
    Clin Cancer Res; 2012 Aug; 18(15):4145-53. PubMed ID: 22675166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer.
    Roscigno M; Brausi M; Heidenreich A; Lotan Y; Margulis V; Shariat SF; Van Poppel H; Zigeuner R
    Eur Urol; 2011 Oct; 60(4):776-83. PubMed ID: 21798659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
    Margulis V; Shariat SF; Matin SF; Kamat AM; Zigeuner R; Kikuchi E; Lotan Y; Weizer A; Raman JD; Wood CG;
    Cancer; 2009 Mar; 115(6):1224-33. PubMed ID: 19156917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
    Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
    BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors impacting survival in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy.
    Mouracade P; Velten M; Gigante M; Alenda O; Ploussard G; Obadia F; Timsit MO; Mejean A
    Can J Urol; 2012 Feb; 19(1):6105-10. PubMed ID: 22316512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
    Fritsche HM; Novara G; Burger M; Gupta A; Matsumoto K; Kassouf W; Sircar K; Zattoni F; Walton T; Tritschler S; Baba S; Bastian PJ; Martínez-Salamanca JI; Seitz C; Otto W; Wieland WF; Karakiewicz PI; Ficarra V; Hartmann A; Shariat SF
    Urol Oncol; 2012 Sep; 30(5):666-72. PubMed ID: 20933445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.
    Sun M; Shariat SF; Cheng C; Ficarra V; Murai M; Oudard S; Pantuck AJ; Zigeuner R; Karakiewicz PI
    Eur Urol; 2011 Oct; 60(4):644-61. PubMed ID: 21741163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma.
    Messer JC; Terrell JD; Herman MP; Ng CK; Scherr DS; Scoll B; Boorjian SA; Uzzo RG; Wille M; Eggener SE; Lucas SM; Lotan Y; Shariat SF; Raman JD
    Urol Oncol; 2013 Aug; 31(6):904-8. PubMed ID: 21906967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic factors of upper tract urothelial carcinomas and impact on survival: a systematic review for the yearly scientific report of the French National Association of Urology].
    Colin P; Irani J; Drouin SJ; Shariat SF; Rouprêt M
    Prog Urol; 2014 Nov; 24(15):1000-10. PubMed ID: 25199726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of molecular markers for the staging and prognosis of upper tract urothelial carcinoma.
    Bagrodia A; Youssef RF; Kapur P; Darwish OM; Cannon C; Belsante MJ; Gerecci D; Sagalowsky AI; Shariat SF; Lotan Y; Margulis V
    Eur Urol; 2012 Jul; 62(1):e27-9. PubMed ID: 22552216
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic significance of tumor necrosis in primary transitional cell carcinoma of upper urinary tract.
    Lee SE; Hong SK; Han BK; Yu JH; Han JH; Jeong SJ; Byun SS; Park YH; Choe G
    Jpn J Clin Oncol; 2007 Jan; 37(1):49-55. PubMed ID: 17204506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy.
    Kuroda K; Asakuma J; Horiguchi A; Tasaki S; Yoshii H; Sato A; Ito K; Seguchi K; Sumitomo M; Asano T
    Urol Int; 2012; 88(2):225-31. PubMed ID: 22236640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.